TG Therapeutics, Inc. (TGTX)

NASDAQ: TGTX · Real-Time Price · USD

52.03

-1.50 (-2.80%)

At close: Jul 31, 2026, 4:00 PM EDT

51.80

-0.23 (-0.44%)

After-hours: Jul 31, 2026, 7:59 PM EDT

TG Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Cap	7,374	4,630	4,691	2,586	1,732	2,722
Market Cap Growth	31.47%	-1.30%	81.36%	49.35%	-36.37%	-62.78%
Enterprise Value	7,613	4,741	4,633	2,480	1,653	2,486
Last Close Price	52.03	29.81	30.10	17.08	11.83	19.00

Price Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	18.12	10.76	200.67	189.78	-	-
Forward PE	31.16	20.29	45.21	134.45	-	-
PEG Ratio	1.37	0.14	0.37	-	-	-
PS Ratio	10.53	7.51	14.26	11.07	621.81	406.90
PB Ratio	12.65	7.14	21.09	16.11	29.56	11.48
P/TBV Ratio	14.34	7.43	21.70	15.80	27.72	10.63

EV Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
EV/Sales Ratio	10.87	7.69	14.08	10.61	593.58	371.66
EV/EBITDA Ratio	50.90	38.43	110.33	118.96	-	-
EV/EBIT Ratio	50.92	38.45	110.51	120.18	-	-

Financial Efficiency

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Debt / Equity Ratio	1.29	0.39	1.14	0.68	1.39	0.32
Debt / EBITDA Ratio	5.04	2.06	6.04	5.32	-	-
Net Debt / Equity Ratio	0.41	0.17	-0.26	-0.66	-1.34	-0.99
Net Debt / EBITDA Ratio	1.60	0.91	-1.36	-5.12	0.36	0.68
Net Debt / FCF Ratio	-16.85	-4.47	1.41	3.40	0.45	0.80
Asset Turnover	0.54	0.75	0.73	0.89	0.01	0.01
Inventory Turnover	0.93	0.85	0.51	0.71	-	-
Quick Ratio	4.84	2.91	4.85	5.00	3.04	4.84
Current Ratio	5.81	4.10	6.25	5.92	3.16	5.06
Return on Equity (ROE)	75.03%	102.75%	12.21%	11.57%	-151.36%	-92.03%
Return on Assets (ROA)	-22.64%	-32.53%	10.04%	8.12%	-76.17%	-68.59%
Return on Invested Capital (ROIC)	-37.09%	-57.71%	41.62%	125.89%	-	-
Return on Capital Employed (ROCE)	13.28%	17.66%	10.99%	9.91%	-96.04%	-80.90%

Yields

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Earnings Yield	6.26%	9.29%	0.50%	0.53%	-	-
Buyback Yield / Dilution	2.27%	-0.67%	-7.96%	-9.67%	-2.41%	-14.64%
Total Shareholder Return	2.27%	-0.67%	-7.96%	-9.67%	-2.41%	-14.64%

SEC Filings: 10-K · 10-Q